Saturday 17 October 2026 Export CRSP’s income statement to Excel — free account

CRISPR Therapeutics AG

CRISPR Therapeutics AG’s revenue for fiscal 2025 (year ended December 2025) was $3.5 million, down 90.6% from fiscal 2024. In the quarter to June 2026, revenue grew 1,041.4%, EPS grew 60.8% and free cash flow grew 26.2%, each against the same quarter a year earlier.

49.30 2.22 −4.31%

Follow CRSP

Alert me

Market cap: $5.0B
P/E: 0.0×
Fwd P/E: −10.8×
Dividend yield: —
F-score: 2/9
Altman Z: 7.04
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	3	2	2	—	+8 more TTM periods Free account
ROE Full definition →	(26.09%)	(31.21%)	(30.18%)	(25.33%)
ROA Full definition →	(19.28%)	(23.24%)	(25.81%)	(21.70%)
ROIC Full definition →	0.00%	0.00%	0.00%	(131,984.38%)
Return on Tangible Assets Full definition →	(19.22%)	(23.45%)	(29.79%)	(25.29%)
Average Days of Receivables Full definition →	0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →	(3.85)	(4.18)	(3.85)	(3.32)
Free Cash Flow Full definition →	(371.32)	(401.18)	(345.93)	(303.14)
Capital Expenditures Full definition →	(1.74)	(1.21)	(0.91)	(0.65)
Other line items
Cash ROIC Full definition →	(7.91%)	(8.29%)	(8.88%)	(7.91%)
Accounts Receivable Turnover Full definition →	0.00	0.00	0.00	0.00
Accounts Payable Turnover Full definition →	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	0.00	0.00	0.00	0.00
Tax Rate Full definition →	0.01	0.01	0.01	0.01
Research and Development Expense of Revenue Full definition →	2,095.48%	9,192.03%	10,856.38%	963.23%
Selling, General and Administrative Expense of Revenue Full definition →	523.19%	1,740.90%	2,095.21%	191.11%
Share Based Compensation of Revenue Full definition →	510.16%	1,672.22%	2,065.50%	199.21%
Operating CF/Net income Full definition →	0.82	0.70	0.59	0.62
Depreciation/Fixed assets Full definition →	0.17	0.17	0.17	0.15
Capex/Depreciation Full definition →	(0.09)	(0.06)	(0.05)	(0.03)
Revenue per Share Full definition →	0.14	0.04	0.04	0.42
Operating CF per Share Full definition →	(3.83)	(4.16)	(3.84)	(3.31)
Capex per Share Full definition →	(0.02)	(0.01)	(0.01)	(0.01)
Capex to Sales Full definition →	0.13	0.30	0.26	0.02

Show all line items

Columns are period end dates

Stockrow Weekly